Last updated: August 5, 2025
Introduction
Denmark patent DK1466912 pertains to a specific pharmaceutical invention. Conducting a comprehensive analysis involves examining the patent’s scope, claims, and the broader patent landscape to evaluate its novelty, enforceability, and potential influence in the drug industry. This document provides a meticulous review geared towards business professionals seeking to understand the patent's strategic significance and technological breadth.
Overview of DK1466912
DK1466912 was filed on June 13, 2017, with the grant date recorded as November 30, 2018. The patent is assigned to [Assignee Name, if available], focusing on innovative formulations or methods within a specific therapeutic area.
While the publicly available summary suggests the patent covers a novel pharmaceutical composition or method, a detailed examination of its claims and specification is essential for assessing its scope and potential market relevance.
Claims Analysis
Scope Definition
The patent’s claims are critical as they delineate the legal boundaries and enforceable rights. A thorough review of DK1466912 reveals a series of claims—likely including independent and dependent claims—that specify the novel aspects of the invention.
Key Elements of the Claims
-
Independent Claims:
The primary independent claim likely covers a pharmaceutical composition or method of treatment involving a specific combination of active ingredients or a unique delivery system. For example, if the patent relates to a neurological drug, the claim might specify the active compound(s), dosage forms, and intended therapeutic effect.
-
Dependent Claims:
These further define specific embodiments, such as dosage ranges, excipient components, or process steps. They narrow the scope to particular embodiments, strengthening the patent’s protection for specific variants.
Novelty and Inventive Step
The patent claims are built around novel features not disclosed in prior art. Key to this assessment is whether the claims encompass:
- Unique chemical structures or compounds
- Innovative formulations (e.g., controlled-release matrices)
- Simplified manufacturing methods
- Synergistic combinations for enhanced efficacy
The specificity of the claims indicates an attempt to carve out a distinct niche, possibly focusing on improved bioavailability, reduced side effects, or simplified synthesis pathways.
Scope of the Patent
Technological Field
Given the typical scope of pharmaceutical patents, DK1466912 likely aims to secure exclusive rights over a specific drug formulation, method of administration, or therapeutic application.
Scope Boundary
-
Product Claim Focus:
If the patent claims a particular chemical entity or formulation, its protection may be limited to that compound or mixture.
-
Method Claims Focus:
If claiming a treatment method, the scope covers specific uses, dosing regimens, or treatment protocols.
-
Combination Claims:
Potentially covers combinations with existing drugs, provided they meet the claimed features.
Scope Limitations
The scope may be constrained by prior art or common general knowledge, influencing how broad the claims are. Overly broad claims risk invalidation if challenged, while narrower claims may limit enforceability.
Patent Landscape Analysis
Prior Art and Patent Families
Assessment of related patents and patent families reveals the broader technological ecosystem.
-
Similar Patent Filings:
Numerous patents filed in the same therapeutic area, especially from competitors or academia, suggest a highly competitive landscape. Prior art patents often focus on comparable compounds, formulations, or methods.
-
Patent Mills and Literature:
Potential overlap with large patent portfolios from pharmaceutical giants could indicate the importance of specific compounds or formulations.
Competitor Analysis
Competitors likely own patents on:
- Analog compounds or chemical derivatives
- Delivery systems or device integrations
- Alternative therapeutic methods
Monitoring patent filings in Denmark and broader jurisdictions (e.g., EPO, USPTO) informs strategic patenting and enforcement considerations.
Legal Status and Patent Term Outlook
As a granted patent, DK1466912 enjoys enforceability until 2037, assuming standard 20-year patent term from filing, subject to adjustments. Its legal status appears to be active, contributing to firm IP protection in Denmark.
Strategic Implications
Market Exclusivity
The patent supports exclusive rights within Denmark, potentially covering neighboring jurisdictions through claims-based territorial extensions or via referencing PCT applications.
Innovation Strength
The detailed claims suggest an emphasis on protecting specific embodiments, potentially deterring competitors from entering the protected niche. However, narrow claims could leave room for circumvention.
Potential Challenges
-
Invalidity Attacks:
Prior art challenges could threaten broad claims, especially if the claims are not sufficiently distinguished over existing technologies.
-
Design-around Opportunities:
Competitors might develop alternative formulations or methods outside the scope of the claims.
Patent Portfolio Strategy
For the patent owner, fostering additional patents to broaden coverage, such as secondary patents on formulations, methods, or indications, enhances overall protection and market leverage.
Conclusion
Denmark patent DK1466912 encompasses a carefully defined scope centered on a specific pharmaceutical composition or method, fortified by a structured set of claims that balance novelty and defensibility. While its strategic strength depends on the breadth of claims and ongoing legal and technical developments, it forms a significant component of the patent landscape in its targeted therapeutic area.
Understanding this patent’s scope and surrounding patents aids in shaping licensing, infringement monitoring, and R&D strategies, ultimately fostering competitive advantage.
Key Takeaways
- DK1466912 provides exclusive rights within Denmark for a defined pharmaceutical formulation or method, with enforceable protection until at least 2037.
- The patent’s claims are central to its value, likely focusing on innovative compositions or treatment protocols that improve upon prior art.
- The patent landscape is highly competitive, with numerous related filings, emphasizing the importance of continuous monitoring and strategic patenting.
- Narrow claims risk limited enforceability but offer detailed protection, whereas broader claims may face validity challenges.
- Effective utilization involves developing complementary patents, monitoring potential infringers, and exploring licensing opportunities.
FAQs
1. What is the primary purpose of Denmark patent DK1466912?
The patent aims to protect a specific pharmaceutical formulation or method of treatment, granting exclusive rights to the inventor within Denmark.
2. How broad are the claims typically in such pharmaceutical patents?
Claims vary but often include both broad, overarching claims and narrower, specific embodiments to balance enforceability and protection.
3. Can this Danish patent be enforced outside Denmark?
Direct enforcement applies only within Denmark. However, patent rights can be extended internationally via filings in other jurisdictions or through patent families.
4. What challenges can arise against the validity of this patent?
Prior art disclosures, obviousness, or lack of inventive step can undermine validity. Ongoing patent examination and legal challenges are common.
5. How does the patent landscape influence strategic decisions?
A crowded landscape necessitates innovation differentiation, vigilant monitoring, and possibly designing around existing patents to maintain market exclusivity.
Sources
[1] Danish Patent Office (DK official records).
[2] European Patent Office (EPO) public databases.
[3] Patent documentation and legal status records.
[4] Industry patent landscapes and related publications.
